Controlling protein expression using a degron is drawing more attention 25 because the protein of interest can be rapidly depleted in a reversible manner. We 26 pioneered the development of the auxin-inducible degron (AID) technology by 27 transplanting a plant-specific degradation pathway to non-plant cells. In human cells 28 expressing an E3 ligase component, OsTIR1, it is possible to degrade a degron-29 fused protein with a half-life of 15-45 min in the presence of the phytohormone auxin. 30
Introduction 41
Conditional depletion of a protein of interest (POI) is a powerful approach to 42 analyse its function in vivo, especially for POIs that are essential for cell viability. 43
Recently, conditional approaches using a degron have been drawing increased 44 attention [1] . A degron-fused protein can be rapidly and efficiently degraded when 45 needed, so that the primary defect arising from the depletion can be observed before 46 the phenotype is complicated or compromised by the secondary defects. For this 47 purpose, we pioneered the establishment of the auxin-inducible degron (AID) 48 technology to control degron-fused proteins in yeast and mammalian cells (Figure 49 1A) [2] . When expressed in non-plant cells, TIR1 of rice (OsTIR1) forms a chimeric 50 SCF (Skp1-Cul1-F box) complex with the other endogenous components. The 51 SCF-OsTIR1 E3 ubiquitin ligase is only activated when IAA or NAA (a natural or 52 synthetic auxin, respectively) is bound ( Figure 1A ). We identified a 7 kD degron 53 termed mini-AID (mAID) and others identified similar AID degrons [3] [4] [5] . A POI fused 54 with a mAID is recognized by SCF-OsTIR1 for ubiquitylation and subsequent 55 proteasomal degradation ( Figure 1A) . 56 Recently, we showed that conditional human cells can be generated by 57 tagging endogenous genes with a mAID cassette using CRISPR-Cas9-based gene 58 tagging [6] . This technology has recently been applied in many studies. One 59 particular example is the assessment of chromosome architectures [7] [8] [9] [10] . Moreover, 60 AID technology has been applied to other model organisms, such as fission yeast, 61 fruit fly, nematode, zebrafish and the parasitic Toxoplasma gondii [11] [12] [13] [14] [15] . These 62 studies support the idea that the AID technology can be used as a standard method 63 to achieve conditional protein depletion. However, a drawback of this technology is 64 that the expression level of mAID-fused proteins can be low in OsTIR1-expressing4 cells [6] . This "basal degradation" might be caused by the presence of contaminating 66 auxin-like chemicals in bovine serum or culture media [1] . To achieve a tight control 67 of the expression of mAID-fused proteins, an improvement in this technology is 68 awaited. 69
Here, we describe a method to generate conditional human HCT116 and 70 DLD1 mutants by homology-directed repair (HDR)-mediated gene tagging using 71 CRISPR-Cas9 ( Figure 1B) . We offer a new series of plasmids for N-or C-terminal 72 tagging with mAID and other tags. To overcome the problems associated with basal 73 degradation, we used a TIR1 inhibitor called auxinole ( Figure 5A ) [16] . It was 74 possible to suppress basal degradation and rapidly recover expression after 75 depletion by supplementing culture media with auxinole. 76 77 2. Construction of CRISPR and donor plasmids for tagging 78 Figure 1B shows the procedures that were used to generate conditional AID 79 cells, which typically required one month of work. We previously reported mAID 80 tagging at the C terminus of a POI ( Figure 2B ) [6] . We now developed a procedure 81 to tag a POI with mAID at the N terminus (Figure 2A) One 96-well plate will be used to prepare a frozen stock and the other will be used to 185 prepare genomic DNA for PCR genotyping. Figure 5B ). This showed that OsTIR1 289 expression, even in the absence of auxin, induced a mitotic phenotype that was 290 analogous to knockdown or inhibition of dynein [19, 20] . The addition of auxinole 291 together with doxycycline clearly suppressed the downregulation of DHC1-mACl and 292 the mitotic arrest ( Figure 5B) . To test whether DHC1-mACl could be rapidly depleted, 293 we added doxycycline with or without auxinole for 24 h. We monitored the 294 expression levels of DHC1-mACl by flow cytometry, and found that basal 295 degradation was mostly suppressed in the cells treated with doxycycline and 296 auxinole ( Figure 5C , compare the boxes shown in red). Subsequently, the culture 297 media was replaced with fresh one containing doxycycline and IAA, but not auxinole. 298 Figure 5C shows that DHC1-mACl was rapidly degraded after medium replacement 299 and was mostly depleted within 4 h. 300
An advantage of AID technology is that the expression level of mAID-fused 301 proteins can be reversibly controlled [2] . We expected that auxinole would be useful 302 for re-expression after depletion, because IAA-bound OsTIR1 can remain active for a 303 while, even after the removal of IAA from the culture medium. To test this idea, we 304 used HCT116 CMV-OsTIR1 cells in which the cohesin subunit RAD21 was fused to 305 mAID-mClover (RAD21-mACl) [6] . Initially, we depleted RAD21-mACl by adding IAA 306 for 24 h ( Figure 6A ). Subsequently, we replaced the medium with fresh media with 307 or without auxinole, and collected time-course samples to monitor the expression 308 levels of RAD21-mACl by flow cytometry ( Figure 6B) . We found that recovery of 309 RAD21-mADl was significantly rapid and sharp when auxinole was added, compared 310 with cells without auxinole. These results suggest that the OsTIR1 inhibitor auxinole 311 is useful for the tight control of the expression of mAID-fused proteins in human cells. 312 313
Conclusion 314
We described a CRISPR-Cas9-based method that can be used to fuse 315 endogenous POIs to mAID and other tags. We developed new plasmids for N-316 terminal tagging, so that it is now possible to tag the N and C termini of POIs (Figure  317 2). To suppress basal degradation in cells expressing OsTIR1, we used the OsTIR1 318 antagonist auxinole ( Figure 5A) . Even in the Tet-OsTIR1 background cells, it is now 319 possible to induce rapid degradation of mAID-fused proteins by inducing OsTIR1 in 320 the presence of auxinole ( Figure 5C ). Moreover, auxinole is useful for the re-321 expression of mAID-fused POIs after depletion ( Figure 6B) . The use of auxinole 322 allows the rapid, tight and efficient control of the expression of mAID-fused POIs. 323
15
Other genetic systems also enable the control of degron-or tag-fused POIs using a 324 chemical ligand [1, [21] [22] [23] . However, to the best of our knowledge, there are no 325 inhibitors that allow the tight control of these systems. AID technology-now 326 combined with the degradation inducer, auxin, and the inhibitor, auxinole-will be 327 particularly useful to dissect biological networks, such as transcriptional cascades, 328 signal transduction and cell-cycle control systems, in which a primary defect caused 329 by the loss of a POI leads to secondary defects. We hope that the method described 330 in this manuscript will enhance the utility of AID technology for functional studies of 331 endogenous proteins in living cells. 
